170 related articles for article (PubMed ID: 35066016)
1. Cynarin blocks Ebola virus replication by counteracting VP35 inhibition of interferon-beta production.
Corona A; Fanunza E; Salata C; Morwitzer MJ; Distinto S; Zinzula L; Sanna C; Frau A; Daino GL; Quartu M; Taglialatela-Scafati O; Rigano D; Reid S; Mirazimi A; Tramontano E
Antiviral Res; 2022 Feb; 198():105251. PubMed ID: 35066016
[TBL] [Abstract][Full Text] [Related]
2. The Host E3-Ubiquitin Ligase TRIM6 Ubiquitinates the Ebola Virus VP35 Protein and Promotes Virus Replication.
Bharaj P; Atkins C; Luthra P; Giraldo MI; Dawes BE; Miorin L; Johnson JR; Krogan NJ; Basler CF; Freiberg AN; Rajsbaum R
J Virol; 2017 Sep; 91(18):. PubMed ID: 28679761
[TBL] [Abstract][Full Text] [Related]
3. Evasion of interferon responses by Ebola and Marburg viruses.
Basler CF; Amarasinghe GK
J Interferon Cytokine Res; 2009 Sep; 29(9):511-20. PubMed ID: 19694547
[TBL] [Abstract][Full Text] [Related]
4. Identification of Myricetin as an Ebola Virus VP35-Double-Stranded RNA Interaction Inhibitor through a Novel Fluorescence-Based Assay.
Daino GL; Frau A; Sanna C; Rigano D; Distinto S; Madau V; Esposito F; Fanunza E; Bianco G; Taglialatela-Scafati O; Zinzula L; Maccioni E; Corona A; Tramontano E
Biochemistry; 2018 Nov; 57(44):6367-6378. PubMed ID: 30298725
[TBL] [Abstract][Full Text] [Related]
5. Insights into Ebola Virus VP35 and VP24 Interferon Inhibitory Functions and their Initial Exploitation as Drug Targets.
Fanunza E; Frau A; Corona A; Tramontano E
Infect Disord Drug Targets; 2019; 19(4):362-374. PubMed ID: 30468131
[TBL] [Abstract][Full Text] [Related]
6. Development of RNA aptamers targeting Ebola virus VP35.
Binning JM; Wang T; Luthra P; Shabman RS; Borek DM; Liu G; Xu W; Leung DW; Basler CF; Amarasinghe GK
Biochemistry; 2013 Nov; 52(47):8406-19. PubMed ID: 24067086
[TBL] [Abstract][Full Text] [Related]
7. DRBP76 associates with Ebola virus VP35 and suppresses viral polymerase function.
Shabman RS; Leung DW; Johnson J; Glennon N; Gulcicek EE; Stone KL; Leung L; Hensley L; Amarasinghe GK; Basler CF
J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S911-8. PubMed ID: 21987769
[TBL] [Abstract][Full Text] [Related]
8. Functional Importance of Hydrophobic Patches on the Ebola Virus VP35 IFN-Inhibitory Domain.
Kasajima N; Matsuno K; Miyamoto H; Kajihara M; Igarashi M; Takada A
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835122
[TBL] [Abstract][Full Text] [Related]
9. Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling.
Cárdenas WB; Loo YM; Gale M; Hartman AL; Kimberlin CR; Martínez-Sobrido L; Saphire EO; Basler CF
J Virol; 2006 Jun; 80(11):5168-78. PubMed ID: 16698997
[TBL] [Abstract][Full Text] [Related]
10. Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs.
Prins KC; Delpeut S; Leung DW; Reynard O; Volchkova VA; Reid SP; Ramanan P; Cárdenas WB; Amarasinghe GK; Volchkov VE; Basler CF
J Virol; 2010 Mar; 84(6):3004-15. PubMed ID: 20071589
[TBL] [Abstract][Full Text] [Related]
11. A Luciferase Reporter Gene Assay to Measure Ebola Virus Viral Protein 35-Associated Inhibition of Double-Stranded RNA-Stimulated, Retinoic Acid-Inducible Gene 1-Mediated Induction of Interferon β.
Cannas V; Daino GL; Corona A; Esposito F; Tramontano E
J Infect Dis; 2015 Oct; 212 Suppl 2():S277-81. PubMed ID: 25926684
[TBL] [Abstract][Full Text] [Related]
12. Structure of the Ebola VP35 interferon inhibitory domain.
Leung DW; Ginder ND; Fulton DB; Nix J; Basler CF; Honzatko RB; Amarasinghe GK
Proc Natl Acad Sci U S A; 2009 Jan; 106(2):411-6. PubMed ID: 19122151
[TBL] [Abstract][Full Text] [Related]
13. Ebola virus VP35 perturbs type I interferon signaling to facilitate viral replication.
Cao Z; Liu C; Peng C; Ran Y; Yao Y; Xiao G; Li E; Chen Z; Chuai X; Chiu S
Virol Sin; 2023 Dec; 38(6):922-930. PubMed ID: 37839549
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis for ebolavirus VP35 suppression of human dendritic cell maturation.
Yen B; Mulder LC; Martinez O; Basler CF
J Virol; 2014 Nov; 88(21):12500-10. PubMed ID: 25142601
[TBL] [Abstract][Full Text] [Related]
15. The Ebola virus VP35 protein binds viral immunostimulatory and host RNAs identified through deep sequencing.
Dilley KA; Voorhies AA; Luthra P; Puri V; Stockwell TB; Lorenzi H; Basler CF; Shabman RS
PLoS One; 2017; 12(6):e0178717. PubMed ID: 28636653
[TBL] [Abstract][Full Text] [Related]
16. Impact of Měnglà Virus Proteins on Human and Bat Innate Immune Pathways.
Williams CG; Gibbons JS; Keiffer TR; Luthra P; Edwards MR; Basler CF
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295912
[TBL] [Abstract][Full Text] [Related]
17. Ebola virus replication is regulated by the phosphorylation of viral protein VP35.
Zhu L; Gao T; Yang W; Liu Y; Liu X; Hu Y; Jin Y; Li P; Xu K; Zou G; Zhao L; Cao R; Zhong W; Xia X; Cao C
Biochem Biophys Res Commun; 2020 Jan; 521(3):687-692. PubMed ID: 31694758
[TBL] [Abstract][Full Text] [Related]
18. Basic residues within the ebolavirus VP35 protein are required for its viral polymerase cofactor function.
Prins KC; Binning JM; Shabman RS; Leung DW; Amarasinghe GK; Basler CF
J Virol; 2010 Oct; 84(20):10581-91. PubMed ID: 20686031
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for Marburg virus VP35-mediated immune evasion mechanisms.
Ramanan P; Edwards MR; Shabman RS; Leung DW; Endlich-Frazier AC; Borek DM; Otwinowski Z; Liu G; Huh J; Basler CF; Amarasinghe GK
Proc Natl Acad Sci U S A; 2012 Dec; 109(50):20661-6. PubMed ID: 23185024
[TBL] [Abstract][Full Text] [Related]
20. Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome.
Luthra P; Ramanan P; Mire CE; Weisend C; Tsuda Y; Yen B; Liu G; Leung DW; Geisbert TW; Ebihara H; Amarasinghe GK; Basler CF
Cell Host Microbe; 2013 Jul; 14(1):74-84. PubMed ID: 23870315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
